ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients
Ann Oncol
.
2018 Feb 1;29(2):523.
doi: 10.1093/annonc/mdx058.
Authors
O Trédan
,
C Ménétrier-Caux
,
I Ray-Coquard
,
G Garin
,
C Cropet
,
E Verronèse
,
T Bachelot
,
P Rebattu
,
P E Heudel
,
P Cassier
,
S Chabaud
,
T Croughs
,
P Dupont
,
A C Cadore
,
G Clapisson
,
A Delgado
,
C Bardin-Dit-Courageot
,
C Rigal
,
A N'Kodia
,
L Gilles-Afchain
,
M Morre
,
D Pérol
,
J Y Blay
,
C Caux
PMID:
28368453
DOI:
10.1093/annonc/mdx058
No abstract available
Publication types
Published Erratum